Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with obstructive sleep apnea (a condition where breathing stops and starts during sleep) and have had a specific implanted device called the Inspire system fitted to help treat it
- People in Group 1: Those who have already had an overnight sleep study done as part of their regular care at Antwerp University Hospital, where the device settings were adjusted
- People in Group 2: Those who have recently had, or are about to have, a daytime sleep study done at Antwerp University Hospital, where the device settings are adjusted
- People who are able to give their agreement to take part after being informed about the trial
Who may not be able to join:
- People who are not able to understand the language used in the trial questionnaires
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Olivier Vanderveken, MD, PhD, University Hospital, Antwerp
Phone: +3238215780
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Non-inferiority of the delta apnea-hypopnea index (AHI) between the two cohorts as measured by a titration polysomnography
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.